Primary differences in lipolysis between human omental and subcutaneous adipose tissue observed using in vitro differentiated adipocytes. 2009

A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
Department of Medicine, Karolinska Institutet at the Karolinska University Hospital, Stockholm 141 86, Sweden.

Catecholamine-induced lipolysis is elevated in omental as compared to subcutaneous adipocytes due to primary differences between the two cell types (i.e., they have different progenitor cells). Whether there is regional variation in atrial natriuretic peptide (ANP)-induced lipolysis is unknown. We studied whether beta-adrenoceptor signaling to lipolysis and ANP-induced lipolysis are involved in the primary differences in lipolysis. In vitro experiments on differentiated preadipocytes from human subcutaneous and omental adipose tissue were performed. The cells were kept in culture for a relative long duration, so any influence of local environment and circulation in the various adipose tissue depots could be excluded. Using beta1-, beta2-, and beta3-adenoceptor agonists, lipolysis was found to be significantly higher in omental as compared to subcutaneous differentiated preadipocytes. Forskolin and dibutyryl cAMP, which act at post-adrenoceptor levels, did not show any regional difference. There was no regional difference in ANP-induced lipolysis. Gene expression of beta1- and beta3-adrenoceptors was higher and beta2-adrenoceptor expression was lower in the omental cells. Omental fat cells have an increased beta-adrenoceptor-mediated lipolysis principally due to primary differences in the early event that couples beta-adrenoceptor subtypes to G-proteins. ANP-induced lipolysis is not subject to primary regional variation.

UI MeSH Term Description Entries
D008066 Lipolysis The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. Lipolyses
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009852 Omentum A double-layered fold of peritoneum that attaches the STOMACH to other organs in the ABDOMINAL CAVITY. Omentums
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
August 1995, Annals of medicine,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
April 1985, Life sciences,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
June 1970, Acta medica Scandinavica,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
February 1983, Diabetes,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
July 1992, The Journal of clinical endocrinology and metabolism,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
September 1970, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
March 1968, The Journal of laboratory and clinical medicine,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
November 2002, American journal of physiology. Endocrinology and metabolism,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
April 2002, Obesity research,
A Dicker, and G Aström, and K Wåhlén, and J Hoffstedt, and E Näslund, and M Wirén, and M Rydén, and P Arner, and V van Harmelen
July 2014, Cell biology international,
Copied contents to your clipboard!